News Conference News ESC 2018 COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure Todd Neale August 27, 2018
News Conference News ESC 2018 Ten-Year Follow-up Proves Disappointing for Bilateral Arterial Grafts in ART Shelley Wood August 26, 2018
News Conference News ESC 2018 Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE Shelley Wood August 26, 2018
News Conference News ESC 2018 Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61 Michael O'Riordan August 26, 2018
News Conference News ESC 2018 FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice Todd Neale August 26, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News ‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions Yael L. Maxwell August 17, 2018
News Daily News TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction Shelley Wood August 15, 2018
News Daily News Edoxaban Looks Good for Asians With A-fib in Real-world Analysis Todd Neale August 14, 2018
News Industry News Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection August 14, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News New AHA Advisory Waffles on Artificially Sweetened Drinks, Citing Dearth of Studies Lucy Hicks August 07, 2018
News Daily News Starting Low and Going Lower: Some Benefit to Very Low LDL Levels Michael O'Riordan August 02, 2018
News Daily News No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT Michael O'Riordan July 23, 2018
News Daily News High-Risk Medical Device Approval Process in Europe Inches Towards Transparency Michael O'Riordan July 20, 2018
News Opinion Fellow Talk Is Your Interventional Career the Scourge of Your Musculoskeletal System? Mesfer Alfadhel, MD July 18, 2018
News Daily News Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51 Michael O'Riordan July 06, 2018
News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Daily News SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function Todd Neale July 02, 2018